JP2024500360A5 - - Google Patents
Info
- Publication number
- JP2024500360A5 JP2024500360A5 JP2023535468A JP2023535468A JP2024500360A5 JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5 JP 2023535468 A JP2023535468 A JP 2023535468A JP 2023535468 A JP2023535468 A JP 2023535468A JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20213488.8 | 2020-12-11 | ||
| EP20213488 | 2020-12-11 | ||
| PCT/EP2021/085366 WO2022123070A1 (en) | 2020-12-11 | 2021-12-13 | Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024500360A JP2024500360A (ja) | 2024-01-09 |
| JP2024500360A5 true JP2024500360A5 (https=) | 2024-07-11 |
| JPWO2022123070A5 JPWO2022123070A5 (https=) | 2024-07-11 |
Family
ID=74187071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535468A Pending JP2024500360A (ja) | 2020-12-11 | 2021-12-13 | 関連づけられた抗原および関連づけられたアジュバントを有する２つのポリマーソーム集団を投与することによる、Ｔｈ１／Ｔｈ２免疫応答の調整方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230398207A1 (https=) |
| EP (1) | EP4259197A1 (https=) |
| JP (1) | JP2024500360A (https=) |
| AU (1) | AU2021396659A1 (https=) |
| CA (1) | CA3193643A1 (https=) |
| WO (1) | WO2022123070A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201704135QA (en) * | 2012-11-19 | 2017-06-29 | Agency Science Tech & Res | Method For Eliciting An Immune Response To An Immunogen |
| EP4604997A2 (en) * | 2022-10-21 | 2025-08-27 | PDS Biotechnology Corporation | Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5354934A (en) | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| EP2281033B1 (en) | 2008-04-17 | 2014-10-15 | Vin de Bona Trading Co Pte | Post release modification of viral envelopes |
| US8323696B2 (en) | 2008-08-29 | 2012-12-04 | Ecole Polytechnique Federale De Lausanne | Nanoparticles for immunotherapy |
| CN102460150B (zh) | 2009-04-20 | 2015-05-20 | 新加坡科技研究局 | 囊泡系统及其用途 |
| EP2601262A4 (en) | 2010-08-05 | 2014-01-22 | Agency Science Tech & Res | VESIGN STRUCTURE WITH SEVERAL CHAMBERS AND METHOD FOR THEIR EDUCATION |
| CA2866170A1 (en) | 2012-03-12 | 2013-09-19 | Advanced Bioadjuvants, Llc | Adjuvant and vaccine compositions |
| DK2906717T3 (en) | 2012-10-11 | 2019-04-01 | Vin De Bona Trading Company Pte Ltd | PROCEDURE FOR PAINTING MICROVESICS |
| SG10201704135QA (en) | 2012-11-19 | 2017-06-29 | Agency Science Tech & Res | Method For Eliciting An Immune Response To An Immunogen |
| KR101943171B1 (ko) * | 2013-09-19 | 2019-01-29 | 조에티스 서비시즈 엘엘씨 | 유성 아쥬반트 |
| EP2898894A1 (en) | 2014-01-27 | 2015-07-29 | LTS LOHMANN Therapie-Systeme AG | Nano-in-micro particles for intradermal delivery |
| US9636397B2 (en) | 2015-03-24 | 2017-05-02 | VaxLiant, LLC | Adjuvant compositions and related methods |
| US10696985B1 (en) * | 2016-06-06 | 2020-06-30 | Vanderbilt University | Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery |
| EP3743101A2 (en) * | 2018-01-25 | 2020-12-02 | ACM Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof |
| CN114502191B (zh) * | 2019-08-01 | 2026-04-03 | Acm生物实验室私人有限公司 | 通过施用具有关联的抗原的聚合物囊泡群和具有关联的佐剂的聚合物囊泡群来引发免疫应答的方法以及包含这两种聚合物囊泡群的组合物 |
| US20230256082A1 (en) * | 2020-04-24 | 2023-08-17 | Acm Biolabs Pte Ltd | Vaccine against human-pathogenic coronaviruses |
-
2021
- 2021-12-13 JP JP2023535468A patent/JP2024500360A/ja active Pending
- 2021-12-13 US US18/256,896 patent/US20230398207A1/en active Pending
- 2021-12-13 EP EP21836471.9A patent/EP4259197A1/en active Pending
- 2021-12-13 CA CA3193643A patent/CA3193643A1/en active Pending
- 2021-12-13 AU AU2021396659A patent/AU2021396659A1/en active Pending
- 2021-12-13 WO PCT/EP2021/085366 patent/WO2022123070A1/en not_active Ceased